| TEMPUS AI INC. DL-,01 |
| USA |
| Gesundheit |
| US88023B1035 / A40EDP |
| F3M (Frankfurt) / TEM (NASDAQ) |
| FRA:F3M, ETR:F3M, F3M:GR, NASDAQ:TEM |
| - |
| https://www.tempus.com/ |
|
Tempus AI, Inc. is a healthcare technology company that applies artificial intelligence and machine learning to advance precision medicine. It builds platforms and provides next-generation diagnostics across key areas including oncology, neuropsychia..
>Volltext.. |
| 7283.74 Mio. EUR |
| 7770.64 Mio. EUR |
| 1101.77 Mio. EUR |
| -122.42 Mio. EUR |
| -212.27 Mio. EUR |
| -1.22 EUR |
| 1149.71 Mio. EUR |
| 523.94 Mio. EUR |
| -188.93 Mio. EUR |
| 2.03 |
| 61.66% |
| 69.4% |
| - |
| - |
| - |
| TEMPUS AI, TEMPUS AI′S, TEMPUS AI S |
| 05.04.26 |
|
||||
|